← Back to Search

Noninvasive Brain Stimulation

Active tDCS for Associative Memory

N/A
Waitlist Available
Led By Sven Vanneste, PhD
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up memory performance changes will be assessed in two different visits. first assessment (baseline) on visit 1 (learning), then one-week after during visit 2 (memory)
Awards & highlights

Study Summary

This trial will test whether a non-invasive brain stimulation technique can help healthy people learn and remember better.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~memory performance changes will be assessed in two different visits. first assessment (baseline) on visit 1 (learning), then one-week after during visit 2 (memory)
This trial's timeline: 3 weeks for screening, Varies for treatment, and memory performance changes will be assessed in two different visits. first assessment (baseline) on visit 1 (learning), then one-week after during visit 2 (memory) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
A Computerized Verbal Paired-associate Memory Task Will be Used to Assess Memory Performance.

Side effects data

From 2012 Phase 3 trial • 60 Patients • NCT01649232
10%
headache
10%
headedness / dizziness
7%
fatigue or nausea
100%
80%
60%
40%
20%
0%
Study treatment Arm
Active tDCS
Controls

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active tDCSExperimental Treatment1 Intervention
active HD-tDCS will be administered
Group II: Sham tDCSPlacebo Group1 Intervention
sham HD-tDCS will be administered
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active tDCS
2012
Completed Phase 3
~1150

Find a Location

Who is running the clinical trial?

The University of Texas at DallasLead Sponsor
58 Previous Clinical Trials
106,245 Total Patients Enrolled
Sven Vanneste, PhDPrincipal InvestigatorThe University of Texas at Dallas
6 Previous Clinical Trials
210 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025